Bruno Gori

467 total citations
15 papers, 339 citations indexed

About

Bruno Gori is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Bruno Gori has authored 15 papers receiving a total of 339 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 6 papers in Pulmonary and Respiratory Medicine and 5 papers in Cancer Research. Recurrent topics in Bruno Gori's work include Colorectal Cancer Treatments and Studies (5 papers), Lung Cancer Treatments and Mutations (5 papers) and Cancer Treatment and Pharmacology (4 papers). Bruno Gori is often cited by papers focused on Colorectal Cancer Treatments and Studies (5 papers), Lung Cancer Treatments and Mutations (5 papers) and Cancer Treatment and Pharmacology (4 papers). Bruno Gori collaborates with scholars based in Italy and Lebanon. Bruno Gori's co-authors include Filippo de Marinis, Ester Del Signore, Antonio Passaro, Serena Ricciardi, Alberto Fulvi, Maria Rita Migliorino, Chiara D’Antonio, Flavia Longo, Carlo Catalano and Fulvio Zaccagna and has published in prestigious journals such as Journal of Clinical Oncology, Radiology and Supportive Care in Cancer.

In The Last Decade

Bruno Gori

14 papers receiving 336 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Bruno Gori Italy	8	180	178	72	56	53	15	339
Benjamin E. Lee United States	7	196 1.1×	229 1.3×	63 0.9×	47 0.8×	48 0.9×	9	421
Hayato Konno Japan	11	195 1.1×	110 0.6×	35 0.5×	56 1.0×	102 1.9×	47	389
Dominique Rosine France	7	154 0.9×	149 0.8×	51 0.7×	59 1.1×	72 1.4×	9	311
Junjie Hong China	11	123 0.7×	50 0.3×	57 0.8×	76 1.4×	82 1.5×	43	339
J.P. Bahary Canada	11	202 1.1×	57 0.3×	64 0.9×	29 0.5×	37 0.7×	21	388
Hikaru Watarai Japan	14	260 1.4×	92 0.5×	55 0.8×	81 1.4×	160 3.0×	36	472
Wichit Arpornwirat Thailand	9	71 0.4×	176 1.0×	58 0.8×	53 0.9×	60 1.1×	17	279
Zhaoyu Xing China	10	166 0.9×	68 0.4×	177 2.5×	47 0.8×	89 1.7×	24	370
Hanxiang Liu China	10	82 0.5×	212 1.2×	120 1.7×	87 1.6×	40 0.8×	25	325
Yuko Nakazawa Japan	11	42 0.2×	125 0.7×	55 0.8×	39 0.7×	62 1.2×	39	380

Countries citing papers authored by Bruno Gori

Since Specialization

Citations

This map shows the geographic impact of Bruno Gori's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bruno Gori with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bruno Gori more than expected).

Fields of papers citing papers by Bruno Gori

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bruno Gori. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bruno Gori. The network helps show where Bruno Gori may publish in the future.

Co-authorship network of co-authors of Bruno Gori

This figure shows the co-authorship network connecting the top 25 collaborators of Bruno Gori. A scholar is included among the top collaborators of Bruno Gori based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bruno Gori. Bruno Gori is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Passaro, Antonio, Massimo Di Maïo, Ester Del Signore, Bruno Gori, & Filippo de Marinis. (2014). Management of Nonhematologic Toxicities Associated With Different EGFR-TKIs in Advanced NSCLC: A Comparison Analysis. Clinical Lung Cancer. 15(4). 307–312. 23 indexed citations

Graziano, Paolo, Filippo de Marinis, Bruno Gori, et al.. (2014). EGFR-Driven Behavior and Intrapatient T790M Mutation Heterogeneity of Non–Small-Cell Carcinoma With Squamous Histology. Journal of Clinical Oncology. 33(31). e115–e118. 14 indexed citations

D’Antonio, Chiara, Antonio Passaro, Bruno Gori, et al.. (2014). Bone and brain metastasis in lung cancer: recent advances in therapeutic strategies. Therapeutic Advances in Medical Oncology. 6(3). 101–114. 162 indexed citations

Passaro, Antonio, Bruno Gori, & Filippo de Marinis. (2013). Afatinib as first-line treatment for patients with advanced non-small-cell lung cancer harboring EGFR mutations: focus on LUX-Lung 3 and LUX-Lung 6 phase III trials.. PubMed. 5(4). 383–4. 9 indexed citations

Sanctis, Rita De, Silvia Quadrini, Ester Del Signore, et al.. (2012). Capecitabine in elderly patients with metastatic breast cancer. IRIS Research product catalog (Sapienza University of Rome). 3 indexed citations

Gori, Bruno, Serena Ricciardi, Alberto Fulvi, Ester Del Signore, & Filippo de Marinis. (2012). New Oral Multitargeted Antiangiogenics in Non-Small-Cell Lung Cancer Treatment. Future Oncology. 8(5). 559–573. 5 indexed citations

Sanctis, Rita De, Silvia Quadrini, Flavia Longo, et al.. (2012). Capecitabine in Elderly Patients with Metastatic Breast Cancer. Tumori Journal. 98(3). 303–307. 3 indexed citations

Gori, Bruno, Serena Ricciardi, Ester Del Signore, Alberto Fulvi, & Filippo de Marinis. (2012). Oral tyrosine kinase inhibitors in the first-line treatment of advanced non-small cell lung cancer. Expert Opinion on Therapeutic Targets. 16(sup2). S55–S60. 3 indexed citations

Gori, Bruno, et al.. (2011). New antiangiogenics in non-small cell lung cancer treatment: Vargatef™ (BIBF 1120) and beyond. Therapeutics and Clinical Risk Management. 7. 429–429. 9 indexed citations

10.

Fraioli, Francesco, Michele Anzidei, Fulvio Zaccagna, et al.. (2011). Whole-Tumor Perfusion CT in Patients with Advanced Lung Adenocarcinoma Treated with Conventional and Antiangiogenetic Chemotherapy: Initial Experience. Radiology. 259(2). 574–582. 64 indexed citations

11.

Longo, Flavia, Andrea Zivi, Domenico Vitolo, et al.. (2011). Efficacy and Tolerability of long-acting Octreotide in the Treatment of Thymic Tumors. American Journal of Clinical Oncology. 35(2). 105–109. 7 indexed citations

12.

Sanctis, Rita De, Silvia Quadrini, Ester Del Signore, et al.. (2011). Safety and Efficacy of Oral Vinorelbine and Capecitabine Combination for Metastatic Breast Cancer. Journal of Chemotherapy. 23(2). 110–113. 2 indexed citations

13.

Longo, Flavia, Giovanni Mansueto, Rita De Sanctis, et al.. (2010). Palonosetron plus 3-day aprepitant and dexamethasone to prevent nausea and vomiting in patients receiving highly emetogenic chemotherapy. Supportive Care in Cancer. 19(8). 1159–1164. 34 indexed citations

14.

Gori, Bruno, et al.. (2009). Utilidad clínica de la Cistatina C como marcador precoz de enfermedad renal crónica. 25(3).

15.

Rosati, Maria Sofia, Cristina Raimondi, Silvia Quadrini, et al.. (2008). WALT trial (Phase I-II): Weekly non-pegylated liposomal anthracycline and taxane combination in first-line breast cancer chemotherapy. Journal of Clinical Oncology. 26(15_suppl). 1097–1097. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact